Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy

Amicus Therapeutics Current Ratio 2007-2018 | FOLD

Amicus Therapeutics current ratio from 2007 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Amicus Therapeutics Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-09-30 $0.60B $0.07B 9.12
2018-06-30 $0.58B $0.05B 10.88
2018-03-31 $0.59B $0.14B 4.21
2017-12-31 $0.39B $0.07B 5.60
2017-09-30 $0.43B $0.07B 6.32
2017-06-30 $0.24B $0.10B 2.39
2017-03-31 $0.30B $0.11B 2.70
2016-12-31 $0.34B $0.11B 3.07
2016-09-30 $0.22B $0.09B 2.59
2016-06-30 $0.22B $0.08B 2.71
2016-03-31 $0.17B $0.06B 2.62
2015-12-31 $0.22B $0.07B 2.94
2015-09-30 $0.24B $0.04B 6.69
2015-06-30 $0.37B $0.02B 21.60
2015-03-31 $0.15B $0.02B 7.20
2014-12-31 $0.16B $0.02B 7.66
2014-09-30 $0.09B $0.01B 6.31
2014-06-30 $0.08B $0.01B 7.11
2014-03-31 $0.07B $0.01B 7.84
2013-12-31 $0.09B $0.01B 8.44
2013-09-30 $0.06B $0.01B 7.48
2013-06-30 $0.08B $0.01B 7.74
2013-03-31 $0.09B $0.01B 10.98
2012-12-31 $0.11B $0.01B 11.32
2012-09-30 $0.11B $0.01B 11.33
2012-06-30 $0.11B $0.02B 5.93
2012-03-31 $0.12B $0.02B 6.49
2011-12-31 $0.07B $0.02B 3.46
2011-09-30 $0.08B $0.02B 4.10
2011-06-30 $0.09B $0.02B 5.22
2011-03-31 $0.10B $0.02B 6.01
2010-12-31 $0.11B $0.02B 6.76
2010-09-30 $0.06B $0.01B 7.42
2010-06-30 $0.07B $0.01B 9.96
2010-03-31 $0.08B $0.01B 9.50
2009-12-31 $0.08B $0.01B 7.19
2009-09-30 $0.09B $0.02B 5.48
2009-06-30 $0.10B $0.02B 6.77
2009-03-31 $0.11B $0.01B 8.84
2008-12-31 $0.12B $0.01B 9.24
2008-09-30 $0.14B $0.02B 9.26
2008-06-30 $0.15B $0.02B 9.58
2008-03-31 $0.16B $0.02B 10.51
2007-12-31 $0.16B $0.02B 10.32
2007-09-30 $0.12B $0.01B 12.61
2007-06-30 $0.13B $0.01B 18.26
2007-03-31 $0.00B $0.00B 0.00
2006-09-30 $0.00B $0.00B 0.00
2006-06-30 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.008B $0.037B
AMICUS THERAPEUTICS is a biopharmaceutical company developing novel, oral therapeutics known as pharmacological chaperones for the treatment of a range of human genetic diseases. Pharmacological chaperone technology involves the use of small molecules that selectively bind to and stabilizeproteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with unmet medical needs. Amicus has completed Phase 2 clinical trials of Amigal(TM) for the treatment of Fabry disease and is conducting Phase 2 clinical trials of Plicera(TM) for the treatment of Gaucher disease.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $123.678B 13.98
Gilead Sciences (GILD) United States $87.306B 10.51
Biogen (BIIB) United States $64.362B 13.03
Celgene (CELG) United States $48.025B 9.32
Illumina (ILMN) United States $47.488B 55.32
Vertex Pharmaceuticals (VRTX) United States $44.411B 77.58
Regeneron Pharmaceuticals (REGN) United States $40.859B 20.70
Alexion Pharmaceuticals (ALXN) United States $25.578B 17.50
BioMarin Pharmaceutical (BMRN) United States $16.708B 0.00
Incyte (INCY) United States $13.922B 384.82
Seattle Genetics (SGEN) United States $9.713B 0.00
Exact Sciences (EXAS) United States $8.548B 0.00
Sarepta Therapeutics (SRPT) United States $8.206B 0.00
BeiGene (BGNE) Cayman Islands $8.102B 0.00
QIAGEN (QGEN) Netherlands $8.070B 25.81
Alnylam Pharmaceuticals (ALNY) United States $7.748B 0.00
Bio-Rad Laboratories (BIO.B) United States $7.518B 48.07
Exelixis (EXEL) United States $6.386B 18.10
Bio-Techne Corp (TECH) United States $5.877B 39.70
Bluebird Bio (BLUE) United States $5.587B 0.00
Amarin (AMRN) Ireland $5.386B 0.00
Alkermes (ALKS) Ireland $5.327B 3428.00
Galapagos (GLPG) Belgium $5.242B 0.00
Guardant Health (GH) United States $3.744B 0.00
Immunomedics (IMMU) United States $3.588B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.584B 0.00
Emergent Biosolutions (EBS) United States $3.413B 28.75
Array BioPharma (ARRY) United States $3.288B 0.00
Horizon Pharma Public (HZNP) Ireland $3.279B 13.49
Allogene Therapeutics (ALLO) United States $3.222B 0.00
ARGENX SE-ADR (ARGX) Netherlands $3.218B 0.00
Ligand Pharmaceuticals (LGND) United States $3.159B 24.17
Intercept Pharmaceuticals (ICPT) United States $3.143B 0.00
Akcea Therapeutics (AKCA) United States $2.835B 0.00
Repligen (RGEN) United States $2.716B 84.82
Genomic Health (GHDX) United States $2.655B 89.63
Ascendis Pharma (ASND) Denmark $2.648B 0.00
Allakos (ALLK) United States $2.638B 0.00
Blueprint Medicines (BPMC) United States $2.599B 0.00
China Biologic Products (CBPO) China $2.525B 17.97
Ultragenyx Pharmaceutical (RARE) United States $2.409B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.349B 0.00
Myriad Genetics (MYGN) United States $2.333B 23.11
MyoKardia (MYOK) United States $2.308B 0.00
Global Blood Therapeutics (GBT) United States $2.266B 0.00
Halozyme Therapeutics (HALO) United States $2.244B 50.06
Acceleron Pharma (XLRN) United States $2.222B 0.00
Arena Pharmaceuticals (ARNA) United States $2.026B 0.00
Atara Biotherapeutics (ATRA) United States $1.962B 0.00
Denali Therapeutics (DNLI) United States $1.921B 0.00
REGENXBIO (RGNX) United States $1.908B 25.59
AnaptysBio (ANAB) United States $1.894B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $1.832B 0.00
Innoviva (INVA) United States $1.780B 10.07
Reata Pharmaceuticals (RETA) United States $1.770B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.632B 0.00
Spark Therapeutics (ONCE) United States $1.565B 0.00
Medicines (MDCO) United States $1.536B 0.00
Rubius Therapeutics (RUBY) United States $1.516B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.504B 119.46
Cambrex (CBM) United States $1.492B 11.15
WAVE Life Sciences (WVE) Singapore $1.425B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.400B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.397B 0.00
Editas Medicine (EDIT) United States $1.386B 0.00
Aimmune Therapeutics (AIMT) United States $1.360B 0.00
Mirati Therapeutics (MRTX) United States $1.319B 0.00
ORCHARD THERAPT (ORTX) United Kingdom $1.308B 0.00
NeoGenomics (NEO) United States $1.297B 107.23
Myovant Sciences (MYOV) United Kingdom $1.261B 0.00
Lion Biotechnologies (IOVA) United States $1.238B 0.00
Insmed (INSM) United States $1.236B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.236B 0.00
G1 THERAPEUTICS (GTHX) United States $1.227B 0.00
Sangamo Therapeutics (SGMO) United States $1.192B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.157B 0.00
Clovis Oncology (CLVS) United States $1.145B 0.00
Fate Therapeutics (FATE) United States $1.089B 0.00
UniQure (QURE) Netherlands $1.081B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.033B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.014B 0.00
Apellis Pharmaceuticals (APLS) United States $1.011B 0.00
Audentes Therapeutics (BOLD) United States $0.996B 0.00
Retrophin (RTRX) United States $0.991B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.949B 0.00
Puma Biotechnology (PBYI) United States $0.920B 0.00
Acorda Therapeutics (ACOR) United States $0.905B 11.46
Solid Biosciences (SLDB) United States $0.899B 0.00
Revance Therapeutics (RVNC) United States $0.853B 0.00
Intra-Cellular Therapies (ITCI) United States $0.840B 0.00
Athenex (ATNX) United States $0.834B 0.00
Novavax (NVAX) United States $0.819B 0.00
Cellectis (CLLS) France $0.806B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.797B 0.00
DBV Technologies (DBVT) France $0.796B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.779B 0.00
Vericel (VCEL) United States $0.760B 0.00
Gritstone Oncology (GRTS) United States $0.758B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.757B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.757B 0.00
Heska (HSKA) United States $0.746B 61.06
AC Immune SA (ACIU) Switzerland $0.721B 0.00
Intellia Therapeutics (NTLA) United States $0.717B 0.00
Aptinyx (APTX) United States $0.699B 0.00
InflaRx (IFRX) Germany $0.691B 0.00
Dynavax Technologies (DVAX) United States $0.681B 0.00
Coherus BioSciences (CHRS) United States $0.677B 0.00
Viking Therapeutics (VKTX) United States $0.676B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.661B 0.00
Principia Biopharma (PRNB) United States $0.660B 0.00
ANI Pharmaceuticals (ANIP) United States $0.651B 12.45
CytomX Therapeutics (CTMX) United States $0.649B 0.00
Scholar Rock Holding (SRRK) United States $0.647B 0.00
TWIST BIOSCIENC (TWST) United States $0.639B 0.00
UROGEN PHARMA (URGN) Israel $0.623B 0.00
Cara Therapeutics (CARA) United States $0.622B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.616B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.607B 0.00
UNITY Biotechnology (UBX) $0.604B 0.00
RA PHARMCTL INC (RARX) United States $0.571B 0.00
AVROBIO (AVRO) United States $0.567B 0.00
Arcus Biosciences (RCUS) United States $0.562B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.561B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.554B 0.00
Arvinas (ARVN) United States $0.552B 0.00
ObsEva SA (OBSV) Switzerland $0.534B 0.00
Epizyme (EPZM) United States $0.533B 0.00
Kura Oncology (KURA) United States $0.526B 0.00
BeyondSpring (BYSI) United States $0.524B 0.00
Eidos Therapeutics (EIDX) United States $0.511B 0.00
Kezar Life Sciences (KZR) United States $0.511B 0.00
Inovio Pharmaceuticals (INO) United States $0.495B 0.00
Senesco Technologies (ELOX) United States $0.469B 0.00
Osiris Therapeutics (OSIR) United States $0.465B 0.00
Prothena (PRTA) Ireland $0.461B 0.00
Anika Therapeutics (ANIK) United States $0.452B 18.69
Zymeworks (ZYME) Canada $0.444B 0.00
Replimune (REPL) United States $0.442B 0.00
PDL BioPharma (PDLI) United States $0.439B 7.17
ZIOPHARM Oncology Inc (ZIOP) United States $0.439B 0.00
Abeona Therapeutics (ABEO) United States $0.432B 0.00
Five Prime Therapeutics (FPRX) United States $0.429B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.428B 0.00
Cytokineticsorporated (CYTK) United States $0.424B 0.00
Sinovac Biotech (SVA) China $0.419B 0.00
Kindred Biosciences (KIN) United States $0.418B 0.00
Zealand Pharma (ZEAL) Denmark $0.407B 4.48
Mesoblast (MESO) Australia $0.400B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.371B 0.00
MediciNova (MNOV) United States $0.370B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.367B 0.00
Sorrento Therapeutics (SRNE) United States $0.357B 58.40
ResTORbio (TORC) United States $0.354B 0.00
Liquidia Technologies (LQDA) United States $0.345B 0.00
Cellular Biomedicine (CBMG) United States $0.341B 0.00
MeiraGTx Holdings (MGTX) United States $0.341B 0.00
Krystal Biotech (KRYS) United States $0.338B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.337B 0.00
Evelo Biosciences (EVLO) United States $0.334B 0.00
LogicBio Therapeutics (LOGC) United States $0.333B 0.00
Stemline Therapeutics (STML) United States $0.329B 0.00
Verastem (VSTM) United States $0.329B 0.00
Agenus (AGEN) United States $0.316B 0.00
Kodiak Sciences (KOD) United States $0.311B 0.00
Albireo Pharma (ALBO) United States $0.303B 0.00
Seres Therapeutics (MCRB) United States $0.302B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.291B 0.00
GAMIDA CELL LTD (GMDA) Israel $0.283B 0.00
Athersys (ATHX) United States $0.279B 0.00
Kadmon Holdings (KDMN) United States $0.275B 0.00
MannKind (MNKD) United States $0.275B 0.00
Sutro Biopharma (STRO) United States $0.273B 0.00
Syros Pharmaceuticals (SYRS) United States $0.272B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.271B 0.00
Merus (MRUS) Netherlands $0.263B 0.00
Geron (GERN) United States $0.263B 0.00
Magenta Therapeutics (MGTA) United States $0.257B 0.00
Celcuity (CELC) United States $0.256B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.254B 0.00
BioDelivery Sciences (BDSI) United States $0.254B 0.00
TOCAGEN INC (TOCA) United States $0.254B 0.00
Intec Pharma (NTEC) Israel $0.252B 0.00
Arbutus Biopharma (ABUS) Canada $0.247B 0.00
Equillium (EQ) United States $0.245B 0.00
Adverum Biotechnologies (ADVM) United States $0.231B 0.00
Aduro Biotech (ADRO) United States $0.222B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.221B 0.00
Strongbridge Biopharma (SBBP) United States $0.218B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.214B 0.00
PSivida (EYPT) United States $0.213B 0.00
Celyad SA (CYAD) Belgium $0.208B 0.00
ADMA Biologics Inc (ADMA) United States $0.206B 0.00
Kamada (KMDA) Israel $0.200B 18.37
Urovant Sciences (UROV) United States $0.197B 0.00
Kala Pharmaceuticals (KALA) United States $0.195B 0.00
Synlogic (SYBX) United States $0.191B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.188B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.187B 0.00
Allena Pharmaceuticals (ALNA) United States $0.184B 0.00
Idera Pharmaceuticals (IDRA) United States $0.178B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.177B 0.00
CorMedix Inc (CRMD) United States $0.176B 0.00
Proteostasis Therapeutics (PTI) United States $0.175B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.170B 0.00
Protagonist Therapeutics (PTGX) United States $0.168B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.168B 0.00
Unum Therapeutics (UMRX) United States $0.167B 0.00
BioTime (BTX) United States $0.165B 0.00
Compugen (CGEN) Israel $0.165B 0.00
ChromaDex (CDXC) United States $0.157B 0.00
Enzo Biochem (ENZ) United States $0.154B 0.00
Cohbar (CWBR) United States $0.152B 0.00
Axovant Sciences (AXON) United Kingdom $0.152B 0.00
Palatin Technologies (PTN) United States $0.150B 18.50
Constellation Pharmaceuticals (CNST) United States $0.150B 0.00
XBiotech (XBIT) United States $0.148B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.142B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.138B 0.00
Cerecor (CERC) United States $0.137B 0.00
Menlo Therapeutics (MNLO) United States $0.128B 0.00
NantKwest (NK) United States $0.126B 0.00
XOMA (XOMA) United States $0.124B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.123B 0.00
Selecta Biosciences (SELB) United States $0.123B 0.00
Catalyst Biosciences (CBIO) United States $0.123B 0.00
Eleven Biotherapeutics (SESN) United States $0.122B 0.00
Pfenex (PFNX) United States $0.121B 0.00
Mersana Therapeutics (MRSN) United States $0.120B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.120B 0.00
Organovo Holdings (ONVO) United States $0.119B 0.00
Spero Therapeutics (SPRO) United States $0.116B 0.00
Pluristem Therapeutics (PSTI) Israel $0.114B 0.00
Applied Genetic Technologies (AGTC) United States $0.112B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.107B 0.00
Cocrystal Pharma (COCP) United States $0.107B 118.67
ETON PHARMACEUT (ETON) United States $0.103B 0.00
Axsome Therapeutics (AXSM) United States $0.101B 0.00
Neothetics (EVFM) United States $0.100B 0.00
Cue Biopharma (CUE) United States $0.098B 0.00
Motif Bio Plc (MTFB) United States $0.096B 0.00
Anavex Life Sciences (AVXL) United States $0.095B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.094B 0.00
Signal Genetics (MGEN) United States $0.090B 0.00
Mustang Bio (MBIO) United States $0.090B 0.00
PHASEBIO PHARMA (PHAS) United States $0.090B 0.00
TIZIANA LIFE SC (TLSA) United Kingdom $0.090B 0.00
Cel-Sci (CVM) United States $0.089B 0.00
Chiasma (CHMA) United States $0.088B 0.00
Provention Bio (PRVB) United States $0.088B 0.00
VBI Vaccines (VBIV) United States $0.087B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.086B 0.00
ScPharmaceuticals (SCPH) United States $0.086B 0.00
Cidara Therapeutics (CDTX) United States $0.085B 0.00
Orgenesis (ORGS) United States $0.084B 0.00
OVID THERAPEUTC (OVID) United States $0.082B 0.00
Monster Digital (INNT) United States $0.081B 0.00
Aptose Biosciences (APTO) Canada $0.079B 0.00
VTv Therapeutics (VTVT) United States $0.075B 0.00
ITUS (ANIX) United States $0.074B 0.00
VolitionRX (VNRX) Singapore $0.074B 0.00
Checkpoint Therapeutics (CKPT) United States $0.073B 0.00
BioXcel Therapeutics (BTAI) United States $0.073B 0.00
Alimera Sciences (ALIM) United States $0.070B 0.00
NewLink Genetics (NLNK) United States $0.067B 0.00
Ophthotech (OPHT) United States $0.066B 0.00
Prima BioMed (IMMP) Australia $0.066B 0.00
Bionano Genomics (BNGO) United States $0.065B 0.00
Bellerophon Therapeutics (BLPH) United States $0.065B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.064B 0.00
Entera Bio (ENTX) Israel $0.063B 0.00
Protalix BioTherapeutics (PLX) Israel $0.062B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.062B 0.00
Fortress Biotech (FBIO) United States $0.061B 0.00
Sophiris Bio (SPHS) United States $0.061B 0.00
Vaccinex (VCNX) United States $0.060B 0.00
Evogene (EVGN) Israel $0.060B 0.00
AEterna Zentaris (AEZS) United States $0.058B 10.97
Merrimack Pharmaceuticals (MACK) United States $0.057B 0.00
VistaGen Therapeutics (VTGN) United States $0.055B 0.00
Alcobra (ARCT) United States $0.055B 0.00
Versartis (ARAV) United States $0.054B 4.70
Trevena (TRVN) United States $0.053B 0.00
OncoSec Medical (ONCS) United States $0.052B 0.00
Arsanis (ASNS) United States $0.052B 0.00
Asterias Biotherapeutics (AST) United States $0.050B 0.00
Caladrius Biosciences (CLBS) United States $0.049B 0.00
Celldex Therapeutics (CLDX) United States $0.048B 0.00
Leap Therapeutics (LPTX) United States $0.047B 0.00
Oncobiologics (OTLK) United States $0.047B 0.00
Aptevo Therapeutics (APVO) United States $0.047B 0.00
Clearside Biomedical (CLSD) United States $0.046B 0.00
Zosano Pharma (ZSAN) United States $0.043B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.043B 0.00
Vascular Biogenics (VBLT) Israel $0.042B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.041B 0.00
Eyenovia (EYEN) United States $0.040B 0.00
Celsion (CLSN) United States $0.038B 0.00
Galena Biopharma (SLS) United States $0.037B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.036B 5.81
AquaBounty Technologies (AQB) United States $0.035B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.035B 0.00
Oncolytics Biotech (ONCY) Canada $0.035B 0.00
Proteon Therapeutics (PRTO) United States $0.034B 0.00
Moleculin Biotech (MBRX) United States $0.033B 0.00
TRACON Pharmaceuticals (TCON) United States $0.033B 0.00
AZURRX BIOPHARM (AZRX) United States $0.031B 0.00
VIVUS (VVUS) United States $0.031B 0.00
GTx (GTXI) United States $0.030B 0.00
Aileron Therapeutics (ALRN) United States $0.030B 0.00
Oragenics (OGEN) United States $0.029B 0.00
Histogenics (HSGX) United States $0.029B 0.00
BioPharmX (BPMX) United States $0.028B 0.00
DiaMedica Therapeutics (DMAC) United States $0.027B 0.00
Vical (VICL) United States $0.027B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.027B 0.00
IMMURON LTD (IMRN) Australia $0.026B 0.00
Curis (CRIS) United States $0.023B 0.00
Titan Pharmaceuticals (TTNP) United States $0.022B 0.00
Novelion Therapeutics (NVLN) Canada $0.022B 0.00
Cleveland BioLabs (CBLI) United States $0.020B 0.00
Benitec Biopharma (BNTC) Australia $0.020B 0.00
Advaxis (ADXS) United States $0.020B 0.00
CytRx (CYTR) United States $0.019B 0.00
Therapix Biosciences (TRPX) Israel $0.019B 9.30
Fibrocell Science Inc (FCSC) United States $0.018B 0.00
Pulmatrix (PULM) United States $0.018B 0.00
GENPREX INC (GNPX) United States $0.018B 0.00
Cellect Biotechnology (APOP) Israel $0.017B 0.00
ATyr Pharma (LIFE) United States $0.017B 0.00
Soligenix (SNGX) United States $0.017B 0.00
Genetic Technologies (GENE) Australia $0.016B 0.00
TrovaGene (TROV) United States $0.016B 0.00
Gemphire Therapeutics (GEMP) United States $0.015B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.015B 0.00
Edge Therapeutics (EDGE) United States $0.015B 0.00
Adial Pharmaceuticals (ADIL) United States $0.014B 0.00
IBio (IBIO) United States $0.013B 0.00
Prana Biotechnology (PRAN) Australia $0.013B 0.00
Novogen (KZIA) Australia $0.013B 0.00
Vital Therapies (VTL) United States $0.011B 0.00
Alliqua BioMedical (ALQA) United States $0.011B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.011B 0.00
RestorGenex (DFFN) United States $0.010B 0.00
Hemispherx BioPharma (HEB) United States $0.010B 0.00
Synthetic Biologics (SYN) United States $0.009B 0.00
Cerulean Pharma (DARE) United States $0.009B 0.00
Aytu Bioscience (AYTU) United States $0.008B 0.00
Neuralstem (CUR) United States $0.008B 0.00
Flex Pharma (FLKS) United States $0.008B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.007B 0.00
MYOS RENS Technology (MYOS) United States $0.007B 0.00
ARCA Biopharma (ABIO) United States $0.007B 0.00
AmpliPhi Biosciences (APHB) United States $0.007B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.004B 0.00
Tenax Therapeutics (TENX) United States $0.002B 0.00
OSMOTICA PHARM (OSMT) United States $0.000B 0.00